| COVID‐19 in solid organ transplant recipients: initial report from the US epicenter MR Pereira, S Mohan, DJ Cohen, SA Husain, GK Dube, LE Ratner, ... American journal of transplantation 20 (7), 1800-1808, 2020 | 875 | 2020 |
| Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019 F Latif, MA Farr, KJ Clerkin, MV Habal, K Takeda, Y Naka, S Restaino, ... JAMA cardiology 5 (10), 1165-1169, 2020 | 220 | 2020 |
| Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease … JA Yang, TS Kato, BP Shulman, H Takayama, M Farr, UP Jorde, ... The Journal of heart and lung transplantation 31 (6), 601-610, 2012 | 180 | 2012 |
| Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction A Chokshi, FH Cheema, KJ Schaefle, J Jiang, E Collado, K Shahzad, ... The Journal of heart and lung transplantation 31 (6), 591-600, 2012 | 176 | 2012 |
| Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic … ES Chung, L Miller, AN Patel, RD Anderson, FO Mendelsohn, J Traverse, ... European heart journal 36 (33), 2228-2238, 2015 | 174 | 2015 |
| Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction MS Kim, TS Kato, M Farr, C Wu, RC Givens, E Collado, DM Mancini, ... Journal of the American College of Cardiology 61 (22), 2253-2261, 2013 | 174 | 2013 |
| Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling TS Kato, A Chokshi, P Singh, T Khawaja, F Cheema, H Akashi, ... Circulation: Heart Failure 4 (5), 546-553, 2011 | 162 | 2011 |
| An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure MS Penn, FO Mendelsohn, GL Schaer, W Sherman, MJ Farr, J Pastore, ... Circulation research 112 (5), 816-825, 2013 | 153 | 2013 |
| Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device TS Kato, PC Schulze, J Yang, E Chan, K Shahzad, H Takayama, N Uriel, ... The Journal of heart and lung transplantation 31 (1), 1-8, 2012 | 149 | 2012 |
| North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension JR Boike, BG Thornburg, SK Asrani, MB Fallon, BE Fortune, MJ Izzy, ... Clinical Gastroenterology and Hepatology 20 (8), 1636-1662. e36, 2022 | 142 | 2022 |
| A change of heart: preliminary results of the US 2018 adult heart allocation revision RR Goff, K Uccellini, K Lindblad, S Hall, R Davies, M Farr, S Silvestry, ... American Journal of Transplantation 20 (10), 2781-2790, 2020 | 131 | 2020 |
| Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation KJ Clerkin, MA Farr, SW Restaino, E Zorn, F Latif, ER Vasilescu, ... The Journal of Heart and Lung Transplantation 36 (5), 540-545, 2017 | 119 | 2017 |
| Serial echocardiography using tissue Doppler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery TS Kato, J Jiang, PC Schulze, U Jorde, N Uriel, S Kitada, H Takayama, ... JACC: Heart Failure 1 (3), 216-222, 2013 | 114 | 2013 |
| Usefulness of two-dimensional echocardiographic parameters of the left side of the heart to predict right ventricular failure after left ventricular assist device implantation TS Kato, M Farr, PC Schulze, M Maurer, K Shahzad, S Iwata, S Homma, ... The American journal of cardiology 109 (2), 246-251, 2012 | 112 | 2012 |
| Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant K Takeda, B Li, AR Garan, VK Topkara, J Han, PC Colombo, MA Farr, ... The Journal of Heart and Lung Transplantation 36 (6), 650-656, 2017 | 106 | 2017 |
| Sex-related differences in use and outcomes of left ventricular assist devices as bridge to transplantation EM DeFilippis, LK Truby, AR Garan, RC Givens, K Takeda, H Takayama, ... JACC: Heart Failure 7 (3), 250-257, 2019 | 96 | 2019 |
| Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement DP Al-Adra, L Hammel, J Roberts, ES Woodle, D Levine, D Mandelbrot, ... American Journal of Transplantation 21 (2), 460-474, 2021 | 87 | 2021 |
| Heart transplantation in human immunodeficiency virus–positive patients N Uriel, UP Jorde, V Cotarlan, PC Colombo, M Farr, SW Restaino, K Lietz, ... The Journal of heart and lung transplantation 28 (7), 667-669, 2009 | 85 | 2009 |
| Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant M Yuzefpolskaya, B Bohn, M Nasiri, AM Zuver, DD Onat, EA Royzman, ... The Journal of Heart and Lung Transplantation 39 (9), 880-890, 2020 | 81 | 2020 |
| Transplantation outcomes with donor hearts after circulatory death JN Schroder, CB Patel, AD Devore, BS Bryner, S Casalinova, A Shah, ... New England Journal of Medicine 388 (23), 2121-2131, 2023 | 79 | 2023 |
